✦ LIBER ✦

Editorial Comment on: Postchemotherapy Retroperitoneal Lymph Node Dissection in Advanced Germ Cell Tumors of the Testis

✍ Scribed by Didier Jacqmin

Book ID: 113610372
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 75 KB
Volume: 53
Category: Article
ISSN: 0302-2838
DOI: 10.1016/j.eururo.2007.10.034

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Editorial Comment on: Postchemotherapy R

Editorial Comment on: Postchemotherapy Retroperitoneal Lymph Node Dissection in Advanced Germ Cell Cancer Tumors of the Testis

✍ Stéphane Culine 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Recurrence in Nonseminomatous Germ Cell

Recurrence in Nonseminomatous Germ Cell Testis Tumor Patients with No Viable Tumor at Postchemotherapy Retroperitoneal Lymph Node Dissection

✍ Philippe E. Spiess; Nizar M. Tannir; Gordon A. Brown; Ping Liu; Shi-Ming Tu; Jam 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 109 KB

Clinical stage I nonseminomatous germ ce

Clinical stage I nonseminomatous germ cell tumors of testis observation vs retroperitoneal lymph node dissection

✍ Stan K. Sujka; Robert P. Huben 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 374 KB

Re: Axel Heidenreich, David Thüer, Serge

Re: Axel Heidenreich, David Thüer, Sergej Polyakov. Postchemotherapy Retroperitoneal Lymph Node Dissection in Advanced Germ Cell Tumours of the Testis. Eur Urol 2008;53:260–74

✍ Yvonne Vergouwe; Ewout W. Steyerberg 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Viable germ cell tumor at postchemothera

Viable germ cell tumor at postchemotherapy retroperitoneal lymph node dissection : Can we predict patients at risk of disease progression?

✍ Philippe E. Spiess; Nizar M. Tannir; Shi-Ming Tu; Gordon A. Brown; Ping Liu; Ash 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB

## Abstract ## BACKGROUND. Patients with viable tumor at time of postchemotherapy retroperitoneal lymph node dissection (PC‐RPLND) are at an increased risk of disease progression. The objective of the current study was to determine the clinical variables that predict this adverse outcome. ## METH

Viable malignant germ cell tumor in the

Viable malignant germ cell tumor in the postchemotherapy retroperitoneal lymph node dissection specimen : Can it be predicted using clinical parameters?

✍ Philippe E. Spiess; Gordon A. Brown; Louis L. Pisters; Ping Liu; Shi-Ming Tu; Ja 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 190 KB